This abstract submission form is for overseas participants only.
If you are a Japanese JSSF member, please submit your abstract
via Japanese abstract submission page.
Abstract Submission Period
Noon, Apr 22(Mon.) –
Noon, May 21 (Tue.), 2024 (JST)
Noon, Jun 4 (Tue.), 2024 (JST)
Noon, Jun 11 (Tue.), 2024 (JST)
Abstract submission is closed.
Thank you for your many submissions.
Please follow the guidelines below to submit your abstract to JSSF2024.
Input items | Mandatory Yes/ No | Restrictions |
---|---|---|
Author Name | YES | The first author must be the speaker. A maximum of 10 co-authors including the first author can be registered. |
Affiliated Institution | YES | Up to 10 affiliations can be registered. |
Abstract Title | YES | Up to 20 words The first letter of each word should be upper case letters (Head Capital). Prepositions and articles should be lower case letters (except at the beginning of sentences). Abbreviations, such as MRI, should be upper case letters; technical terms that should be lower case letters only, should be lower case letters. Words after a "-" (hyphen) should begin with lower case letters. |
Abstract Body | YES | Up to 200 words Please type colon (:) after each section title to make it easier to read. e.g.) Introduction: Materials and Methods: Background: Methods: Purpose: Results: Object: Conclusion: No chart, graphic, figure and table can be uploaded. |
How to Submit
Please download the Abstract Submission Form from the “Abstract Submission Form” button below and send it to the Congress Secretariat for JSSF2024 Program (jssf2024-abs@congre.co.jp) by e-mail.
Attention
- Please send to the Congress Secretariat for JSSF2024 Program well before of the deadline. Many abstract submission e-mails will be sent to it from a few days before the deadline and the day of the deadline. This puts a lot of load on the server and may delay the e-mail and cause you to miss the deadline.
- Please contact the Congress Secretariat for JSSF2024 if you do not receive a confirmation e-mail after two business days from your abstract submission as your abstract may not have been successfully submitted.
Please check the items below before submitting your abstract.
- Are all required fields completed?
- Is the same information being entered in duplicate?
- Are the abstract title and abstract text within the word limit?
Categories
Please select an appropriate category for your abstract from the list of below.
Subject
01 | Treatment Selection for Ankle Osteoarthritis |
---|---|
02 | Medial Column Reconstruction in Adult Flatfoot |
03 | Intra-operative Correction Goals for Hallux Valgus |
04 | Lateral Ankle Ligament Repair : Comparison of Scopic and Open Surgery |
05 | Basic Research on Foot and Ankle |
06 | Nerve Disorder of the Foot |
07 | Correction of Paralyzed Foot / Ankle and Foot Deformities |
08 | Review 20 years after the Introduction of the Ponseti Method |
09 | Pathophysiology and Treatment of Freiberg Disease |
10 | Treatment of Achilles Tendon Enthesopathy |
11 | Treatment of Charcot Joint |
12 | Repair of the Distal Tibiofibular Ligament and Deltoid Ligament |
13 | Pathophysiology and Diagnosis of Lisfranc Joint Injuries |
14 | Minimally Invasive Surgery for Calcaneal Fractures |
15 | Fatigue Fractures of the Ankle Joint, Midfoot and Hindfoot |
16 | Return to Sports after Trauma |
17 | Post-operative and Post-traumatic Rehabilitation |
18 | Trial of New Treatment Methods |
19 | Foot Orthoses and Shoes |
General Presentation Category
01. Diagnosis‧Basics | 01-01. Anatomy‧Biomechanics |
---|---|
01-02. Imaging and Pathology | |
01-03. Ultrasonography | |
01-04. Others | |
02. Conservative and Adjunctive Therapy |
02-01. Rehabilitation |
02-02. Footwear and Orthotics | |
02-03. Foot Care | |
02-04. Perioperative Management (including DVT) | |
02-05. Regenerative Medicine | |
02-06. Other | |
03. Peripheral Nenerve | 03-01. Morton's Disease |
03-02. Tarsal Tunnel Syndrome | |
03-03. Other Peripheral Nerve Disorders | |
04. Inflammatory and Neoplastic Diseases |
04-01. Rheumatoid Foot |
04-02. Rheumatic and Musculoskeletal Diseases | |
04-03. Infection (including Infectious Arthritis and Osteomyelitis) |
|
04-04. Bone Tumors | |
04-05. Soft Tissue Tumors | |
04-06. Other Inflammatory and Neoplastic Diseases | |
05. Pediatric Foot Disorders | 05-01. Congenital Clubfoot |
05-02. Symptomatic Clubfoot | |
05-03. Congenital Foot Deformity (excluding Club Foot) |
|
05-04. Tarsal Coalition | |
05-05. Other Pediatric Foot Disorders | |
06. Foot Disorders | 06-01. Hallux Valgus |
06-02. Hallux Rigidus | |
06-03. Freiberg's Disease | |
06-04. Forefoot Deformity (excluding Hallux Valgus and Hallux Rigidus) |
|
06-05. Flatfoot (including Tibialis Posterior Tendon Dysfunction) |
|
06-06. Paralyzed Foot, Foot Deformity | |
06-07. Other Foot Disorders (including Nail Disorder) | |
07. Sports-related Disorders | 07-01. Osteochondal Lesion of the Talus |
07-02. Ankle Impingement Syndrome | |
07-03. Fatigue Fracture | |
07-04. Disorder of the Sesamoid Bone and Accessory Bone |
|
07-05.Oother Sports-related Disorders | |
08. Osteoarthritis | 08-01. Ankle Osteoarthritis |
08-02. Subtalar Osteoarthritis | |
08-03. Charcot Joint | |
08-04. Other Osteoarthritis | |
09. Fracture and Dislocation | 09-01. Fracture of the Ankle Joint |
09-02. Pilon Fracture | |
09-03. Talus Fracture | |
09-04. Calcaneal Fracture | |
09-05. Fracture of Lisfranc Joint | |
09-06. Fracture and Dislocation of the Midfoot and Forefoot |
|
09-07. Other Fracture/Dislocation | |
10. Ligament Injuries | 10-01. Lateral Ankle Ligament Injury (Fresh) |
10-02. Chronic Ankle Instability | |
10-03. Tibiofibular Ligament Injury | |
10-04. Deltoid Ligament Injury | |
10-05. Lisfranc Ligament Injury | |
10-06. Other Ligament Injuries | |
11. Tendon Disorders (excluding Tibialis Posterior Tendon Dysfunction) |
11-01. Achilles Tendon Rupture (including Negrected) |
11-02. Achilles Tendinopathy/Enthesopathy | |
11-03. Peroneal Tendon Disorders | |
11-04. Plantar Fasciitis | |
11-05. Other Tendon Injuries | |
12. Other |
Notification
Notification of acceptance/rejection will be sent to the submitting authors by late July 2024.
As your abstract will be accepted, please kindly note in advance we would make a request for the participant registration.
The details will be posted on this website as soon as they are finalized.
Abstract Submission
Abstract Submission Form
This abstract submission form is for overseas participants only.
If you are a Japanese JSSF member, please submit your abstract
via Japanese abstract submission page.
Inquiries about abstract submission
Congress Secretariat for JSSF2024 Program
c/o Congrès Inc.
E-mail:jssf2024-abs@congre.co.jp